Bill Snyder

January 8, 2025

Study suggests a new way to treat incurable lung disease

IPF is one of the most common forms of pulmonary fibrosis, an interstitial lung disease characterized by the progressive accumulation of scar tissue (fibrosis) in the epithelial lining of the airways.

By Bill Snyder
January 2, 2025

2025 New Year’s baby Siora Ray arrives only 12 minutes after midnight

First baby at VWCH: Cash Mitchell; first baby at VTHH: Gwennyth Trinity Grace Freeze-Stele.

By Bill Snyder
December 19, 2024

Proteomic signature a key to early detection of fatty liver disease: study

Currently, methods to detect early, obesity-related accumulation of fat in the liver other than a liver biopsy — the surgical removal of liver tissue for microscopic examination — are limited. But there is hope.

By Bill Snyder
December 17, 2024

Immune-suppressing drug does not improve COVID-19 recovery: study

Previous studies suggested that fostamatinib may suppress inflammatory responses triggered by COVID-19 and mitigate ongoing lung injury, decreasing mortality and oxygen requirements.

By Bill Snyder
(iStock image)
December 16, 2024

VUMC awarded $26.4 million for patient-centered research

The awards support research efforts to identify optimal approaches to improving health care and health outcomes for patients, families and the community.

By Bill Snyder
December 11, 2024

Vanderbilt joins national effort to develop alphavirus vaccines

The project aims to design computational “tool kits” that can speed development of multi-virus vaccines targeting some of the greatest infectious threats to human health.

By Bill Snyder and Herschel Pollard
December 10, 2024

Therapy for genetic epilepsy in children showing promise

Preliminary results of a clinical trial of 4-phenylbutyrate (PBA) “show a significant reduction in seizure activity among participants.”
By Bill Snyder
November 25, 2024

Potential treatment eyed for abnormal blood cell disorder

Research could lead to improved diagnosis and the first effective treatment for the disorder, called “clonal hematopoiesis of indeterminant potential,” or CHIP. 
By Bill Snyder
November 19, 2024

Eleven Vanderbilt scientists among world’s ‘highly cited’ researchers

The list recognizes both the scientific achievements of individual scientists and “their profound impact on tackling broader societal challenges.”
By Bill Snyder
November 12, 2024

Patient voices critical to success of artificial intelligence in health care

Sponsored by the Department of Biomedical Informatics, the symposium showcased the work of the department’s center for AI Discovery and Vigilance to Accelerate Innovation and Clinical Excellence.
By Bill Snyder
November 4, 2024

James Crowe Jr. honored for his innovative research on human antibodies

Crowe and his colleagues have developed cutting-edge technologies to isolate and study antiviral antibodies.
By Bill Snyder
October 28, 2024

Microsoft’s Eric Horvitz set for next Discovery Lecture

Horvitz, an elected member of the National Academy of Engineering, is a pioneer in the applications of machine learning, AI and decision science.
By Bill Snyder
1 2 3 … 115